Summary: The Rotarex Atherectomy System is a device used for mechanical thrombectomy and atherectomy in arterial applications. Key evidence highlights its effectiveness in treating lower limb ischemia and arterial occlusions.
The Rotarex Atherectomy System was cleared by the FDA through the 510(k) pathway on September 14, 2021. It is manufactured by C.R. Bard and classified as a Class 2 device under product code MCW.
What It Is
The Rotarex Atherectomy System is a rotational excisional device designed for the removal of thrombus and atheromatous plaque from peripheral arteries. It is intended for use in patients with peripheral arterial disease to restore blood flow.
Clinical Applications
Common clinical scenarios for the Rotarex Atherectomy System include treatment of acute and chronic lower limb ischemia, limb graft occlusion post-endovascular aneurysm repair, and femoropopliteal arterial disease.
Evidence Summary
The available literature includes 12 studies, comprising case series and prospective studies, published between 2020 and 2025. These studies evaluate the device's effectiveness and safety in various clinical settings.
Reported Outcomes
Published studies report that the Rotarex Atherectomy System is effective in revascularizing occluded arteries, particularly in cases of lower limb ischemia and limb graft occlusion. The device has shown success in both acute and chronic settings, with improvements in blood flow and limb salvage rates.
Safety Profile
Reported complications include arterial dissections and potential for vessel injury, as observed in some studies. However, the overall safety profile is considered acceptable within the context of its clinical use.
Evidence Limitations
Current evidence is limited by the small sample sizes and the lack of randomized controlled trials. Further research is needed to establish long-term outcomes and to compare the device's efficacy against other treatment modalities.
Frequently Asked Questions
What are the clinical indications for Rotarex Atherectomy System?
The Rotarex Atherectomy System is indicated for mechanical thrombectomy and atherectomy in patients with peripheral arterial disease, particularly for treating lower limb ischemia and arterial occlusions.
What outcomes have been reported in clinical studies?
Clinical studies have reported successful revascularization and improved blood flow in occluded arteries, with positive outcomes in both acute and chronic ischemic conditions.
What complications have been reported?
Safety data from evidence indicate complications such as arterial dissections and potential vessel injury, though these are generally manageable within clinical practice.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.
📬 Stay Updated
Get the latest vascular education content delivered to your inbox.